Cancer-fighting T cells usually have to be made for an individual patient, but UCLA scientists have developed a way to produce them from cord blood instead.
The researchers engineered immune cells from stem cells found in donated umbilical cord blood and gave them two separate ways to recognise cancer. In experiments involving mice with ovarian cancer and melanoma, the cells controlled tumors and extended survival while avoiding a dangerous immune reaction associated with conventional donor-derived T cells.
